The drug SU5416 is specifically designed to block angiogenesis.
Angiogenesis is the growth of new blood vessels, which is necessary for cancer growth.
An estimated 13,700 Americans will be diagnosed with multiple myeloma this year. About 11,400 Americans are expected to die of the disease. Multiple myeloma is cancer of the plasma cells, which are an important part of the immune system. It multiplies and spreads throughout the bone marrow. Ph.D, director of the lymphoma service.